Yukihiko Kimura

Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease

Norihiro Nishimoto, Yuzuru Kanakura, Katsuyuki Aozasa et al. · Blood · 2005 · 745 citations · Full text

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

Shigeki Ohtake, Shuichi Miyawaki, Hiroyuki Fujita et al. · Blood · 2010 · 257 citations · Full text

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

Shuichi Miyawaki, Shigeki Ohtake, Shin Fujisawa et al. · Blood · 2010 · 171 citations · Full text

A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 study

Norio Asou, Yuji Kishimoto, Hitoshi Kiyoi et al. · Blood · 2007 · 156 citations · Full text

Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome

Masamitsu Yanada, Tadashi Matsushita, Norio Asou et al. · European Journal Of Haematology · 2006 · 127 citations